BluMaiden Biosciences
Damien Keogh is the Chief Executive Officer, Director, and Founder at BluMaiden Biosciences, a biotechnology company focusing on human-first drug discovery within the human microbiome. Prior to this, Damien was the CEO and Co-Founder of Maiden Therapeutics and worked as a Venture Capital Entrepreneur In Residence at EVX Ventures. Damien also held roles as a Senior Research Fellow at Nanyang Technological University and as a Lecturer in Molecular Biology at Dublin City University. Damien holds a PhD in Molecular Biology from Dublin City University.
This person is not in any teams
This person is not in any offices
BluMaiden Biosciences
BluMaiden Biosciences is a biotechnology company that adopts a human-first approach. We enable better drug discovery by probing the vastness of chemical space hidden within the human microbiome. Leveraging immense AI-powered computational genetics and chemistry engines, we illuminate new frontiers for new medicines. The Company is currently involved in several clinical trials and collaborations with clinical institutions, biotechnology companies, and Pharma to address challenges and provide enhanced support in clinical research and drug discovery. Run by an accomplished founding team and backed by a panel of experienced global investors and scientific advisors, BluMaiden is building a sustainable business with an enduring competitive advantage.